{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:08:08Z","timestamp":1778836088372,"version":"3.51.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T00:00:00Z","timestamp":1759708800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012818","name":"Community of Madrid","doi-asserted-by":"publisher","award":["PEJ-2020-AI\/BMD-17954"],"award-info":[{"award-number":["PEJ-2020-AI\/BMD-17954"]}],"id":[{"id":"10.13039\/100012818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014365","name":"Instituto de Investigaci\u00f3n Sanitaria Gregorio Mara\u00f1\u00f3n","doi-asserted-by":"publisher","award":["PROEX 055.7\/22"],"award-info":[{"award-number":["PROEX 055.7\/22"]}],"id":[{"id":"10.13039\/501100014365","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI23\/00086"],"award-info":[{"award-number":["FI23\/00086"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["FI19\/00173"],"award-info":[{"award-number":["FI19\/00173"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["DTS23\/00037"],"award-info":[{"award-number":["DTS23\/00037"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI18\/00506"],"award-info":[{"award-number":["PI18\/00506"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00473"],"award-info":[{"award-number":["PI22\/00473"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024028","name":"Hospital General Universitario Gregorio Mara\u00f1\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.trsl.2025.09.004","type":"journal-article","created":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T14:42:06Z","timestamp":1759675326000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Enhancing specific thymic Treg activation and function with 4-1BB monomeric streptavidin-based CARs"],"prefix":"10.1016","volume":"284","author":[{"given":"Jorge","family":"Gallego-Valle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica Astrid","family":"P\u00e9rez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Pita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Rosales-Magallares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roc\u00edo","family":"L\u00f3pez-Esteban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Gil-Manso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Carbonell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ram\u00f3n","family":"P\u00e9rez-Caballero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Pardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Miguel","family":"Gil-Jaurena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Correa-Rocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1828-4745","authenticated-orcid":false,"given":"Marjorie","family":"Pion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.trsl.2025.09.004_bib0001","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2025.09.004_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1287465","article-title":"Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases","volume":"14","author":"Ou","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2025.09.004_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864748","article-title":"Cytolytic CD4+ and CD8+ regulatory T-cells and implications for developing immunotherapies to combat graft-versus-host disease","volume":"13","author":"Bolivar-Wagers","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.trsl.2025.09.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2024.102069","article-title":"Therapy with regulatory T-cell infusion in autoimmune diseases and organ transplantation: a review of the strengths and limitations","volume":"85","author":"Alhosseini","year":"2024","journal-title":"Transpl Immunol"},{"issue":"4","key":"10.1016\/j.trsl.2025.09.004_bib0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"issue":"13","key":"10.1016\/j.trsl.2025.09.004_bib0006","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1182\/blood-2006-06-027409","article-title":"Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion","volume":"108","author":"Hoffmann","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2025.09.004_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893576","article-title":"A novel GMP protocol to produce high-quality treg cells from the pediatric thymic tissue to Be employed as cellular therapy","volume":"13","author":"Bernaldo-de-Quir\u00f3s","year":"2022","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.trsl.2025.09.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231045","article-title":"First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant","volume":"220","author":"Bernaldo-de-Quir\u00f3s","year":"2023","journal-title":"J Exp Med"},{"issue":"2","key":"10.1016\/j.trsl.2025.09.004_bib0009","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1182\/blood-2006-05-025460","article-title":"In vitro-expanded donor alloantigen-specific CD4+CD25+ regulatory T cells promote experimental transplantation tolerance","volume":"109","author":"Golshayan","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2025.09.004_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686530","article-title":"Highly purified alloantigen-specific tregs from healthy and chronic kidney disease patients can Be long-term expanded, maintaining a suppressive phenotype and function in the presence of inflammatory cytokines","volume":"12","author":"Cort\u00e9s-Hern\u00e1ndez","year":"2021","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.trsl.2025.09.004_bib0011","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/ajt.17063","article-title":"Anti-HLA-A2-CAR tregs prolong vascularized mouse heterotopic heart allograft survival","volume":"22","author":"Wagner","year":"2022","journal-title":"Am J Transplant"},{"issue":"11","key":"10.1016\/j.trsl.2025.09.004_bib0012","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41577-024-01035-3","article-title":"Chimeric antigen receptor T cell therapy for autoimmune disease","volume":"24","author":"Chung","year":"2024","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.trsl.2025.09.004_bib0013","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"557","key":"10.1016\/j.trsl.2025.09.004_bib0014","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci Transl Med"},{"issue":"19","key":"10.1016\/j.trsl.2025.09.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167215","article-title":"Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection","volume":"8","author":"Rosado-S\u00e1nchez","year":"2023","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0016","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1053\/j.gastro.2009.01.049","article-title":"Amelioration of colitis by genetically engineered murine regulatory T cells redirected by antigen-specific chimeric receptor","volume":"136","author":"Elinav","year":"2009","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.trsl.2025.09.004_bib0017","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1158\/0008-5472.CAN-10-0552","article-title":"In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy","volume":"71","author":"Lee","year":"2011","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.trsl.2025.09.004_bib0018","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.trsl.2025.09.004_bib0019","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160674","article-title":"Murine CAR19 tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses","volume":"7","author":"Bolivar-Wagers","year":"2022","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.trsl.2025.09.004_bib0020","article-title":"Tregs with an MHC class II peptide-specific chimeric antigen receptor prevent autoimmune diabetes in mice","volume":"133","author":"Spanier","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2025.09.004_bib0021","doi-asserted-by":"crossref","unstructured":"Cochrane R.W., Robino R.A., Granger B., et al. High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells. bioRxiv. 2024.","DOI":"10.1101\/2024.03.31.587467"},{"issue":"4","key":"10.1016\/j.trsl.2025.09.004_bib0022","doi-asserted-by":"crossref","first-page":"E450","DOI":"10.1073\/pnas.1524193113","article-title":"Versatile strategy for controlling the specificity and activity of engineered T cells","volume":"113","author":"Ma","year":"2016","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"7","key":"10.1016\/j.trsl.2025.09.004_bib0023","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-11-3890","article-title":"A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor","volume":"72","author":"Urbanska","year":"2012","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0024","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13045-018-0677-2","article-title":"Universal CARs, universal T cells, and universal CAR T cells","volume":"11","author":"Zhao","year":"2018","journal-title":"J Hematol Oncol"},{"issue":"8","key":"10.1016\/j.trsl.2025.09.004_bib0025","doi-asserted-by":"crossref","first-page":"e458","DOI":"10.1038\/bcj.2016.61","article-title":"Switching CAR T cells on and off: a novel modular platform for retargeting of T cells to AML blasts","volume":"6","author":"Cartellieri","year":"2016","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1368604","article-title":"mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting","volume":"7","author":"Lohmueller","year":"2017","journal-title":"Oncoimmunology"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0027","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/bit.24605","article-title":"Stable, high-affinity streptavidin monomer for protein labeling and monovalent biotin detection","volume":"110","author":"Lim","year":"2013","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/j.trsl.2025.09.004_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1448752","article-title":"High specificity of engineered T cells with third generation CAR (CD28-4-1BB-CD3-\u03b6) based on biotin-bound monomeric streptavidin for potential tumor immunotherapy","volume":"15","author":"Gallego-Valle","year":"2024","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.trsl.2025.09.004_bib0029","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/ni.3540","article-title":"An essential role for the IL-2 receptor in T reg cell function","volume":"17","author":"Chinen","year":"2016","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.trsl.2025.09.004_bib0030","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/ni.1791","article-title":"Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis","volume":"10","author":"Murai","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.trsl.2025.09.004_bib0031","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaut.2018.02.006","article-title":"Engrafting human regulatory T cells with a flexible modular chimeric antigen receptor technology","volume":"90","author":"Koristka","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.trsl.2025.09.004_bib0032","article-title":"Chimeric antigen receptor costimulation domains modulate human regulatory T cell function","volume":"5","author":"Boroughs","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.trsl.2025.09.004_bib0033","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1166135","article-title":"Opportunities for treg cell therapy for the treatment of human disease","volume":"14","author":"Bluestone","year":"2023","journal-title":"Front Immunol"},{"issue":"20","key":"10.1016\/j.trsl.2025.09.004_bib0034","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92865","article-title":"T cells expressing chimeric antigen receptor promote immune tolerance","volume":"2","author":"Pierini","year":"2017","journal-title":"JCI Insight"},{"issue":"10","key":"10.1016\/j.trsl.2025.09.004_bib0035","doi-asserted-by":"crossref","first-page":"5034","DOI":"10.4049\/jimmunol.171.10.5034","article-title":"Reprogramming of IL-10 activity and signaling by IFN-gamma","volume":"171","author":"Herrero","year":"2003","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0036","doi-asserted-by":"crossref","first-page":"6446","DOI":"10.1038\/s41467-021-26844-1","article-title":"Transient mTOR inhibition rescues 4-1BB CAR-tregs from tonic signal-induced dysfunction","volume":"12","author":"Lamarth\u00e9e","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051182","article-title":"Hinge and transmembrane domains of chimeric antigen receptor regulate receptor expression and signaling threshold","volume":"9","author":"Fujiwara","year":"2020","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0038","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1158\/2159-8290.CD-19-0945","article-title":"Tuning the antigen density requirement for CAR T-cell activity","volume":"10","author":"Majzner","year":"2020","journal-title":"Cancer Discov"},{"issue":"544","key":"10.1016\/j.trsl.2025.09.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aat6753","article-title":"Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function","volume":"11","author":"Salter","year":"2018","journal-title":"Sci Signal"},{"key":"10.1016\/j.trsl.2025.09.004_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.639818","article-title":"The CD28-transmembrane domain mediates chimeric antigen receptor heterodimerization with CD28","volume":"12","author":"Muller","year":"2021","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.trsl.2025.09.004_bib0041","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.trsl.2025.09.004_bib0042","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1091\/mbc.e05-07-0631","article-title":"Granule-mediated killing by granzyme B and perforin requires a mannose 6-phosphate receptor and is augmented by cell surface heparan sulfate","volume":"17","author":"Veugelers","year":"2006","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.trsl.2025.09.004_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.864748","article-title":"Cytolytic CD4+ and CD8+ regulatory T-cells and implications for developing immunotherapies to combat graft-versus-host disease","volume":"13","author":"Bolivar-Wagers","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.trsl.2025.09.004_bib0044","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/ajt.14185","article-title":"Expression of a chimeric antigen receptor specific for donor HLA class I enhances the potency of Human regulatory T cells in preventing Human skin transplant rejection","volume":"17","author":"Boardman","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trsl.2025.09.004_bib0045","article-title":"CD39 delineates chimeric antigen receptor regulatory T cell subsets with distinct cytotoxic & regulatory functions against human islets","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0046","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.4049\/jimmunol.1502139","article-title":"Cutting edge: regulatory T cells facilitate cutaneous wound healing","volume":"196","author":"Nosbaum","year":"2016","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0047","doi-asserted-by":"crossref","first-page":"7863","DOI":"10.1038\/s41467-024-51353-2","article-title":"Local administration of regulatory T cells promotes tissue healing","volume":"15","author":"Nayer","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.trsl.2025.09.004_bib0048","article-title":"IL23R-specific CAR tregs for the treatment of Crohn's disease","author":"Cui","year":"2024","journal-title":"J Crohns Colitis"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0049","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1038\/s41467-024-46448-9","article-title":"Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus","volume":"15","author":"Doglio","year":"2024","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.trsl.2025.09.004_bib0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/nmeth.1226","article-title":"Mapping and quantifying mammalian transcriptomes by RNA-seq","volume":"5","author":"Mortazavi","year":"2008","journal-title":"Nat Methods"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0051","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156132","article-title":"Prediction and quantification of splice events from RNA-seq data","volume":"11","author":"Goldstein","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.trsl.2025.09.004_bib0054","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/nbt.1621","article-title":"Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation","volume":"28","author":"Trapnell","year":"2010","journal-title":"Nat Biotechnol"},{"issue":"1","key":"10.1016\/j.trsl.2025.09.004_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/eji.201141651","article-title":"Suppression assays with human T regulatory cells: a technical guide","volume":"42","author":"McMurchy","year":"2012","journal-title":"Eur J Immunol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524425000921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524425000921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:15:14Z","timestamp":1778832914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524425000921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":53,"alternative-id":["S1931524425000921"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2025.09.004","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing specific thymic Treg activation and function with 4-1BB monomeric streptavidin-based CARs","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2025.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}